Offer - Urjas Oil for just ₹ 1 X
Glytrate 6.4 Mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Angina. Glytrate 6.4 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Glytrate 6.4 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Glytrate 6.4 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Glytrate 6.4 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Glytrate 6.4 Mg Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Glytrate 6.4 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Anemia, Low Blood Pressure (Hypotension) must refrain from the use of Glytrate 6.4 Mg Tablet since this can cause severe adverse effects. The section on Glytrate 6.4 Mg Tablet contraindications lists all such conditions.
Additionally, Glytrate 6.4 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Glytrate 6.4 Mg Tablet is not safe while driving, and is is not addictive in nature.
Glytrate 6.4 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glytrate 6.4 Mg Tablet safe for pregnant women?
Glytrate can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Glytrate right away. Take your doctor's advice before taking it again.
Is the use of Glytrate 6.4 Mg Tablet safe during breastfeeding?
Glytrate may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Glytrate, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Glytrate.
What is the effect of Glytrate 6.4 Mg Tablet on the Kidneys?
Glytrate is not harmful for kidneys.
What is the effect of Glytrate 6.4 Mg Tablet on the Liver?
Very few cases of side effects of Glytrate on the liver have been reported.
What is the effect of Glytrate 6.4 Mg Tablet on the Heart?
Glytrate may have mild side effects on the heart. Most people will never see any effect on the heart.
Glytrate 6.4 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Glytrate 6.4 Mg Tablet unless your doctor advises you to do so -
Is this Glytrate 6.4 Mg Tablet habit forming or addictive?
Forming a habit of Glytrate 6.4 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Glytrate 6.4 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Glytrate 6.4 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Glytrate 6.4 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Glytrate 6.4 Mg Tablet
Taking Glytrate 6.4 Mg Tablet with food does not cause any problems.
Interaction between Alcohol and Glytrate 6.4 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Glytrate 6.4 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 916-917
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 542-543
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (nitroglycerin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gonitro (nitroglycerin)